Kristen Scholer, Hive editor Jon Kelly, and the VF Hive panel discuss the top five stories of the week in technology, politics in business. Nick Bilton reports on his story about Donald Trump's threats to devalue the social media platforms that gave him his rise.
Nick also weighs in on early Facebook executive Chamath Palihapitiya's assertion that social media is tearing society apart. Scholer, Kelly and Bilton discuss whether that's true, and whether Facebook and Twitter will reach an inflection point.
Hive panelist Bess Levin talks about the latest trouble in Trumpland, with commerce secretary Wilbur Ross being accused of insider trading. Abigail Tracy reports on her story about Nikki Haley's potential political ambitions in 2020.
T.A. Frank winds up the Hive 5 with his analysis of the recent Senate Special Election in Alabama. Frank and the panel discuss Roy Moore's defeat and unlikely victory for Democrat Doug Jones. They cover the potential for future Democratic victories in Alabama, as well as Charles Barkley's message to the state prior to the election.
Republican presidential candidate Vivek Ramaswamy tried to sway Iowa voters during Wednesday night's CNN Republican presidential town hall in Des Moines.
A judge says Donald Trump’s 2020 election interference case in Washington will be put on hold while the former president further pursues his claims that he is immune from prosecution.
The Supreme Court on Wednesday said it will hear an appeal that could upend hundreds of charges stemming from the Capitol riot, including against former President Donald Trump.
The Federal Reserve kept its key interest rate unchanged Wednesday for a third straight time, and its officials signaled that they expect to make three quarter-point cuts to their benchmark rate next year.
Hunter Biden on Wednesday defied a congressional subpoena to appear privately for a deposition before Republican investigators who have been digging into his business dealings, insisting outside the U.S. Capitol that he will only testify in public.
The Supreme Court agreed on Wednesday to take up a dispute over a medication used in the most common method of abortion in the United States, its first abortion case since it overturned Roe v. Wade last year.
